Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | necrostatin-7 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | RAF265 | FIMM | pan-cancer | AAC | -0.065 | 0.7 |
mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.019 | 0.7 |
mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |